Patent · US Active

Aptamers for targeting coagulation factor XIII and uses thereof

US11421234B2 · kind B2 · utility

0Cited by
0References
17Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 2, 2019
Grant dateAug 23, 2022
Priority date
Expiry dateMar 2, 2041

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2320/31
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Provided herein is an aptamer specific to coagulation factor XIII (FXIII) and its uses thereof. Accordingly, the present aptamer is useful as a bio-tool to label thrombi, and/or as a targeting molecule to deliver drugs to thrombotic area. Therefore, the present disclosure also pertains to methods for treating diseases associated with FXIII, such as thrombosis.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.